Msn Laboratories
Msn Laboratories, officially known as Msn Laboratories Pvt. Ltd., is a prominent player in the pharmaceutical industry, headquartered in India. Established in 2003, the company has rapidly expanded its operations across major regions, including Europe, the Americas, and Asia, solidifying its position in the global market. Specialising in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, Msn Laboratories is recognised for its commitment to quality and innovation. The company’s core products include a diverse range of therapeutic solutions, particularly in the fields of oncology, cardiology, and anti-infectives, setting it apart with its robust research and development capabilities. With a strong market presence, Msn Laboratories has achieved several milestones, including regulatory approvals from major health authorities, which underscores its dedication to excellence and reliability in the pharmaceutical sector.
DitchCarbon Score
How does Msn Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Msn Laboratories's score of 12 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Msn Laboratories's reported carbon emissions
In 2023, Msn Laboratories reported total carbon emissions of approximately 209,090,370 kg CO2e, with Scope 1 emissions accounting for about 109,040,650 kg CO2e and Scope 2 emissions at approximately 83,016,740 kg CO2e. The company has not disclosed any Scope 3 emissions data for this year. For the previous year, 2024, Msn Laboratories' emissions were broken down into Scope 1, Scope 2, and Scope 3 categories. Scope 1 emissions totalled approximately 135,767,630 kg CO2e, while Scope 2 emissions reached about 126,073,600 kg CO2e. Notably, Scope 3 emissions were reported at approximately 66,735,710 kg CO2e, which included various categories such as purchased goods and services (about 12,726,040 kg CO2e) and business travel (approximately 5,835,350 kg CO2e). Despite these significant emissions figures, Msn Laboratories has not established any specific reduction targets or climate pledges as part of their sustainability initiatives. The absence of documented reduction strategies indicates a potential area for improvement in their climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 109,040,650 | 000,000,000 |
| Scope 2 | 83,016,740 | 000,000,000 |
| Scope 3 | - | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Msn Laboratories is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
